Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
03/2005
03/31/2005CA2521811A1 Haloalkyl containing compounds as cysteine protease inhibitors
03/30/2005EP1518861A2 Process for making group II metal overbased sulfurized alkylphenols
03/30/2005EP1518553A2 Use of nitrate ester compounds for treating pain or providing analgesia
03/30/2005EP1517889A2 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
03/30/2005EP1517888A2 Method for synthesis of hydrogenofluoromethylenesulphonyl radical derivatives
03/30/2005EP1517886A1 Novel phthalamide derivatives
03/30/2005EP1517885A2 Aminoacetonitrile derivatives suitable for controlling parasites
03/30/2005EP1517883A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
03/30/2005EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators
03/30/2005EP1517731A1 Method for producing specific crystalline modifications of polymorphous substances
03/30/2005EP1517680A1 Benzoic acid derivatives as modulators of ppar alpha and gamma
03/30/2005EP1517679A1 Ortho-substituted benzoic acid derivatives for the treatment of insulin resistance
03/30/2005EP1446496A4 Methods for ligand discovery
03/30/2005EP1010690B1 Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural and horticultural use
03/30/2005CN1602300A Process for the preparation of an enantiomerically enriched thio compound
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/30/2005CN1602184A Compounds for a controlled release of active molecules
03/30/2005CN1600772A Aryl phenyl substituted cyclic ketoenols
03/29/2005US6872851 Melatonergic receptors; antiinflammatory agents; anticancer agents
03/29/2005US6872838 Derivatives of water insoluble drugs which exhibit good activity and water solubility
03/26/2005CA2482033A1 Process for making group ii metal overbased sulfurized alkylphenols
03/24/2005WO2005026110A1 Optically active 3,3'-dithiobis(2-amino-2­methylpropionic acid) derivative and process for producing optically active 2-amino-3-mercapto-2-methyl­propionic acid derivative
03/24/2005WO2005025557A1 An agent for plasminogen-activation and matrix metalloproteinase associated conditions and methods of use
03/24/2005WO2004046162A8 Non-steroidal fxr agonists
03/24/2005US20050065121 Using probucol ester
03/24/2005US20050065033 Method to inhibit ethylene responses in plants
03/24/2005US20050064130 Acrylic ester-containing compound of given formula, for example, 1-cyano-2-((2-(p-aminophenyl)ethenyl)phenyl)-acrylic acid, 8-(biphenyloxy)octyl ester
03/23/2005EP1516870A1 Process for producing aromatic compound derivative by reaction of aromatic compound substituted with sulfamoyloxy, sulfinamoyloxy, or carbamoyloxy group, with nucleophilic agent
03/23/2005EP1515978A1 Sulfur-containing phospholipid derivatives
03/23/2005EP1515947A1 Fluorinated cycloalkyl-derivatised benzoylguanidines and their use as a medicament
03/23/2005EP1515940A2 Aminoalkoxy-functional chalcones
03/23/2005EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors
03/23/2005CN1599716A Aminoacetonitrile derivatives and their use for controlling parasites
03/23/2005CN1599712A Process for the preparation of methionine
03/23/2005CN1193987C Prepn process of mercapto acetamide
03/23/2005CN1193986C Phenolic compounds and recording materials containing the same
03/23/2005CN1193983C Acylacetonitriles, process for preparation thereof and miticides containing the same
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/22/2005US6869975 Linked biaryl compounds
03/22/2005US6869904 Bridged bi-aromatic ligands, catalysts, processes for polymerizing and polymers therefrom
03/22/2005CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same
03/17/2005WO2005023844A1 Compound modified with glycerol derivative
03/17/2005WO2004111008A3 Use of a compound of formula i for making a pharmaceutical composition
03/17/2005WO2004110418A3 Carbonyl compounds as inhibitors of histone deacetylase for the treatment of disease
03/17/2005WO2004083867A3 Modulators of g protein-coupled formyl peptide receptor-like 2 and their therapeutic use against cell death-related disorders
03/17/2005WO2003101425A3 Therapeutic agent-containing polymeric nanoarticles
03/17/2005US20050059842 Reacting diamine with sulfonyl halide of water, solvent and base; sulfonamidation, salt formation; hydrogenation catalysts; metallization
03/17/2005US20050059729 Substituted cyclic compounds
03/17/2005US20050059713 Antiviral agents for the treatment, preventions, or amelioration of viral infections; for example, 3-Biphenyl-4-yl-(2S)-[(3'-chloro-4'-fluoro-4-hydroxy-biphenyl-3-carbonyl)-amino]-propionic acid methyl ester
03/17/2005US20050059705 May be antagonists of the intrinsic clotting pathway by binding to and inhibiting the function of factor XI or of both factors XI and IX; for example, 2(S)-{[7-(4-tert-Butyl-phenoxy)-1-cyclopentylmethyl-isoquinoline-3-carbonyl]-amino}-3-(5-phenyl-thiophen-2-yl)-propionic acid; anticoagulants
03/17/2005US20050059611 such as 3-{4-[1-(4-Cyclohex-1-enylphenyl)-3-(3,5-dichlorophenyl)ureidomethyl]benzoylamino}-2,2-difluoropropionic acid), used for treatment and/or prevention of hyperglycemia, diabetes, lipid metabolism disorders and obesity
03/16/2005EP1513825A2 Anti tubercular drug: compositions and methods
03/16/2005EP1513803A1 Ligands that are inhibitors of the rar receptors
03/16/2005EP1513802A1 Alpha-sulfonylamino-acetonitriles
03/16/2005EP1513795A2 Propionic acid derivatives and their use as hppars activators
03/16/2005EP1513526A1 Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as hppar activators
03/16/2005EP1215200B1 Aromatic diamide derivatives or salts thereof, agricultural/horticultural chemicals and method of using the same
03/16/2005EP1049664B1 Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
03/16/2005EP0716604B1 Thiol-derivatized nucleosides and oligonucleosides
03/16/2005CN1594245A Application of ketene thioacetal derivatives as thioalcohol substituted reagent
03/16/2005CN1193012C 2, 5-dimethoxy-4-ethyl phenethyl amine sulfide hydrochloride and preparation process and use thereof
03/15/2005US6867298 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency
03/15/2005US6867284 Fluorinated oligopeptides especially those having 4,4-difluoro- 2-amino butyric acid at the C terminus
03/15/2005US6867203 Cinnamide derivatives with aryl sulfide functionality; cerebral vasospasm
03/15/2005US6866963 Cathode active material and lithium battery employing the same
03/10/2005WO2005022213A1 Optical filter
03/10/2005WO2005021493A2 A method of isolating a thiol
03/10/2005WO2005021487A1 Cathepsin inhibitors
03/10/2005WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/10/2005WO2005000795A3 Aniline derivatived androgen-, glucocorticoid-, mineralcorticoid- and progesterone- receptor modulators
03/10/2005WO2004103962A3 Alkoxy alkylsulfanyl phenols
03/10/2005US20050054883 1-hydroxy-1-(5-norbornene-2-yl)-2,2,4,4,4-pentafluorobutane-3-one; 1-(5-norbornene-2-yl)-2,2,4,4,4-pentafluorobutane-1,3,3-triol; excellent in transparency to irradiation, dry etching resistance, has low hydrophobicity, excellent in development characteristics, useful for photoresist resin
03/10/2005US20050054671 Derivatives of alpha-phenylthiocarboxylic and $g(a)-phenyloxy-carboxylic acids useful for the treatment of diseases responding to pparalpha activation
03/10/2005US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression
03/10/2005US20050054559 Compounds for sustained release of orally delivered drugs
03/10/2005US20050054536 Reacting an cyanoacrylate compound with amidine compound
03/10/2005CA2772017A1 Agricultural/horticultural insecticide and method for using the same
03/10/2005CA2535366A1 Cathepsin inhibitors
03/10/2005CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression
03/09/2005EP1512704A1 High refractive index, UV-curable monomers and coating compositions prepared therefrom
03/09/2005EP1511724A1 Process for the preparation of thioalkylamine derivatives
03/09/2005EP1511718A1 N-acylaminobenzene dervatives as selective monoamine oxidase b inhibitors
03/09/2005EP1511472A2 Compounds useful in the treatment of anthrax and inhibiting lethal factor
03/09/2005EP1200502B1 Amine hardener for epoxy resins
03/09/2005CN1592737A Process for the preparation of cilastatin
03/09/2005CN1592735A Novel alpha-oxygenated or alpha-thiolated carboxylic acid phenethylamide derivatives
03/09/2005CN1590372A Arylphenyl-substituted cyclic ketoenols
03/09/2005CN1192018C Cell adhesive-inhibiting anti inflammatory and immune-suppressive compounds
03/09/2005CN1192015C Cell adhesion inhibitors
03/09/2005CN1192011C Calcium receptor-active arylalkyl amines
03/08/2005US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents
03/08/2005US6864290 Statine derivatives for the treatment of Alzheimer's disease
03/08/2005US6864289 Insecticides
03/08/2005US6864287 Cardiovascular disorders; hypotensive agents
03/08/2005US6864254 Kidney diosrders; brain disorders
03/08/2005US6864246 Anticholesterol agents
03/03/2005WO2005019165A1 Maillard reaction compounds of cysteine and a sugar having meatlike flavour
03/03/2005WO2005019151A1 Ppar modulators
03/03/2005WO2005018628A1 Compounds for the treatment of metabolic disorders
03/03/2005WO2005018529A2 Phenoxiacetic acid derivatives
1 ... 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 ... 272